Market Place
Sourcing Support
Endo Launches New Dupuytren`s Contracture Campaign: Reminders
10 Jun 2024 //
PR NEWSWIRE
Endo Provides Select Q1 2024 Financial Results
30 May 2024 //
PR NEWSWIRE
Endo Peyronie`s Disease Data At AUA Annual Meeting
07 May 2024 //
PR NEWSWIRE
Endo, Inc. Completes Acquisition of Endo International plc`s Assets
23 Apr 2024 //
PR NEWSWIRE
Endo Prices $1.5B Senior Secured Term Loan In $2.5B Exit Financing
11 Apr 2024 //
PR NEWSWIRE
Endo, Inc. Announces Proposed Private Offering of Senior Secured Notes
08 Apr 2024 //
PR NEWSWIRE
Endo, Inc. Announces Proposed New Senior Secured Credit Facilities
01 Apr 2024 //
PR NEWSWIRE
Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS®
26 Mar 2024 //
PR NEWSWIRE
Endo Announces Confirmation of Plan of Reorganization
19 Mar 2024 //
PR NEWSWIRE
Endo Reports Fourth-Quarter 2023 Financial Results
06 Mar 2024 //
PR NEWSWIRE
Endo inks $465M bankruptcy deal settling criminal and civil opioid cases
01 Mar 2024 //
ENDPTS
Endo agrees to bankruptcy settlement with federal government
29 Feb 2024 //
FIERCE PHARMA
Endo Announces Publication of New XIAFLEX Survey Data in Journal
24 Jan 2024 //
PR NEWSWIRE
Endo`s Paladin Labs Announces Launch of XCOPRI® (cenobamate tablets) in Canada
22 Jan 2024 //
PR NEWSWIRE
Endo brings men to the pool hall for straight talk on Peyronie`s
30 Nov 2023 //
FIERCE PHARMA
Endo Announces Five Presentations at the SMSNA Annual Meeting
16 Nov 2023 //
PR NEWSWIRE
Endo Reports Third-Quarter 2023 Financial Results
06 Nov 2023 //
PR NEWSWIRE
Endo sues Zydus to block generic version of Pfizer`s Chantix
11 Aug 2023 //
REUTERS
Endo Reports Second-Quarter 2023 Financial Results
08 Aug 2023 //
PR NEWSWIRE
Bankrupt Endo says government objections imperil $600 mln in opioid settlements
26 Jul 2023 //
REUTERS
Endo Launches Bivalirudin Injection in Ready-to-Use Vials
18 Jul 2023 //
PR NEWSWIRE
Endo and Premier, Inc. Collaborate to Address Pitocin Shortage
17 Jul 2023 //
PR NEWSWIRE
Endo Presents New Data at American Podiatric Medical Association Annual Meeting
13 Jul 2023 //
PR NEWSWIRE
Endo Announces Approval of XCOPRI (cenobamate tablets) in Canada
30 Jun 2023 //
PR NEWSWIRE
Endo Launches First Generic Version of Noxafil® (posaconazole) Injection
29 Jun 2023 //
PR NEWSWIRE
Endo Announces Approval of XCOPRI™ (cenobamate tablets) in Canada
29 Jun 2023 //
PR NEWSWIRE
ENDO REPORTS FIRST-QUARTER 2023 FINANCIAL RESULTS
08 May 2023 //
PR NEWSWIRE
Endo Announces Launch of Argatroban Injection Through Premier`s ProRx
17 Apr 2023 //
PR NEWSWIRE
Endo Launches Authorized Generic Version of Noxafil Oral Suspension
03 Apr 2023 //
PR NEWSWIRE
US government to impose inflation penalties on 27 drugs
16 Mar 2023 //
REUTERS
Endo to Cease Production and Sale of Qwo
06 Dec 2022 //
PRNEWSWIRE
Endo loses appeal challenging generic version of best-seller Vasostrict
19 Aug 2022 //
REUTERS
Endo files for bankruptcy, signs $450M opioid settlement
18 Aug 2022 //
FIERCEPHARMA
Endo Enters Into Restructuring Support Agreement with Senior Secured Debtholders
16 Aug 2022 //
PRNEWSWIRE
Faced with many opioid lawsuits, Endo willfile for bankruptcy `imminently`
10 Aug 2022 //
ENDPOINTS NEWS
Health Canada accepts Paladin’s NDS for epilepsy-linked seizure therapy
09 Aug 2022 //
PHARMACEUTICAL-TECHNOLOGY
ENDO REPORTS SECOND-QUARTER 2022 FINANCIAL RESULTS
09 Aug 2022 //
PRNEWSWIRE
Endo Announces Agreement for Quoin Pharmaceuticals` QRX003 in Canada
15 Jul 2022 //
PRNEWSWIRE
With opioid litigation looming, Endo looking at bankruptcy play
14 Jul 2022 //
FIERCEPHARMA
Endo adds to a pileup of bad news as lead drug flunks PhII study
02 Jul 2022 //
ENDPTS
Opana® ER Antitrust Trial Concludes With Jury Verdict in Endo`s Favor
01 Jul 2022 //
PRNEWSWIRE
Drugmaker Endo misses $38 million interest payment amid bankruptcy talks
30 Jun 2022 //
REUTERS
TLC Announces TLC599 Agreement with Endo
13 Jun 2022 //
GLOBENEWSWIRE
Endo Executes Agreement With TLC to Commercialize PIII Orthopedic Product
13 Jun 2022 //
PRNEWSWIRE
Buxton Helmsley Issues Letter to Endo International Shareholders and Creditors
13 May 2022 //
BUSINESSWIRE
Endo Aesthetics to Introduce New Clinical Study of Qwo
05 May 2022 //
PRNEWSWIRE
ENDO REPORTS FIRST-QUARTER 2022 FINANCIAL RESULTS
05 May 2022 //
PRNEWSWIRE
Endo Acquires Six Development-Stage, Ready-to-Use Injectable From Nevakar
02 May 2022 //
PRNEWSWIRE
Tennessee Court of Appeals Orders Recusal of Trial Court Judge
20 Apr 2022 //
PRNEWSWIRE
Alabama settles for $276M with McKesson, J&J and Endo over opioid crisis
19 Apr 2022 //
ENDPTS
Endo to Announce First-Quarter 2022 Financial Results
12 Apr 2022 //
PRNEWSWIRE
Endo Begins Shipment of Premixed Ephedrine Sulfate Injection
28 Mar 2022 //
PRNEWSWIRE
Endo Launches New Living Our Values Program for Outstanding Team Members
03 Mar 2022 //
PRNEWSWIRE
Endo Launches First Direct-to-Consumer Campaign for Qwo With 200+ Patient Events
02 Mar 2022 //
PRNEWSWIRE
Endo introduces ready-to-use Vasostrict in pre-mix bottles
08 Feb 2022 //
PHARMABIZ
Endo Launches Ready-to-Use VASOSTRICT in Pre-Mix Bottles
07 Feb 2022 //
PRNEWSWIRE
Drugmaker Endo signs $65 mln opioid settlement with Florida
18 Jan 2022 //
REUTERS
Endo Reaches Agreement Intended to Settle Florida Governmental Opioid Cases
18 Jan 2022 //
PRNEWSWIRE
Endo Announces Publication of New AVEED Data in Peer-Reviewed Journal
13 Jan 2022 //
PRNEWSWIRE
Par Pharma begins shipping of US FDA approved generic Cuvposa oral solution
06 Jan 2022 //
PHARMABIZ
